AI Article Synopsis

  • When the endoplasmic reticulum (ER) experiences stress, it can lead to diseases like neurodegeneration, but deleting a specific effector (CHOP) provides protection for neurons.
  • Researchers found that three tricyclic compounds, including maprotiline, can reduce ER stress by blocking the histamine receptor H1 (HRH1).
  • Administering maprotiline in mouse models showed it protects retinal ganglion cells and preserves vision, suggesting it’s a promising option for treating conditions like glaucoma by restoring ER homeostasis.

Article Abstract

When the protein or calcium homeostasis of the endoplasmic reticulum (ER) is adversely altered, cells experience ER stress that leads to various diseases including neurodegeneration. Genetic deletion of an ER stress downstream effector, CHOP, significantly protects neuron somata and axons. Here we report that three tricyclic compounds identified through a small-scale high throughput screening using a CHOP promoter-driven luciferase cell-based assay, effectively inhibit ER stress by antagonizing their common target, histamine receptor H1 (HRH1). We further demonstrated that systemic administration of one of these compounds, maprotiline, or CRISPR-mediated retinal ganglion cell (RGC)-specific HRH1 inhibition, delivers considerable neuroprotection of both RGC somata and axons and preservation of visual function in two mouse optic neuropathy models. Finally, we determine that maprotiline restores ER homeostasis by inhibiting HRH1-mediated Ca release from ER. In this work we establish maprotiline as a candidate neuroprotectant and HRH1 as a potential therapeutic target for glaucoma.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649812PMC
http://dx.doi.org/10.1038/s41467-022-34682-yDOI Listing

Publication Analysis

Top Keywords

maprotiline restores
8
restores homeostasis
8
histamine receptor
8
retinal ganglion
8
somata axons
8
maprotiline
4
homeostasis rescues
4
rescues neurodegeneration
4
neurodegeneration histamine
4
receptor inhibition
4

Similar Publications

Immune checkpoint inhibitors (ICIs) are drugs that inhibit immune checkpoint (ICP) molecules to restore the antitumor activity of immune cells and eliminate tumor cells. Due to the limitations and certain side effects of current ICIs, such as programmed death protein-1, programmed cell death-ligand 1, and cytotoxic T lymphocyte-associated antigen 4 (CTLA4) antibodies, there is an urgent need to find new drugs with ICP inhibitory effects. In this study, a network-based computational framework called multi-network algorithm-driven drug repositioning targeting ICP (Mnet-DRI) is developed to accurately repurpose novel ICIs from ≈3000 Food and Drug Administration-approved or investigational drugs.

View Article and Find Full Text PDF
Article Synopsis
  • When the endoplasmic reticulum (ER) experiences stress, it can lead to diseases like neurodegeneration, but deleting a specific effector (CHOP) provides protection for neurons.
  • Researchers found that three tricyclic compounds, including maprotiline, can reduce ER stress by blocking the histamine receptor H1 (HRH1).
  • Administering maprotiline in mouse models showed it protects retinal ganglion cells and preserves vision, suggesting it’s a promising option for treating conditions like glaucoma by restoring ER homeostasis.
View Article and Find Full Text PDF

Isoflurane-induced neurotoxicity has attracted much interest. Recent studies suggest that isoflurane causes microglial activation, resulting in an inflammatory response and microglial insult. Maprotiline is a novel drug that has been licensed as an antidepressant with considerable anti-inflammatory activity.

View Article and Find Full Text PDF

We studied heart rate variability and β-adrenergic responsiveness of erythrocytes and changes in these parameters in response to single administration of β-adrenoblocker propranolol (2 mg/kg) in outbred male rats against the background of activation of the noradrenergic, serotonergic, and dopaminergic neurotransmitter systems achieved by 4-fold injections maprotiline (10 mg/kg), 5-hydroxytryptophan (50 mg/kg) combined with fluoxetine (3 mg/kg), and L-DOPA (20 mg/kg) with amantadine (20 mg/kg), respectively. Stimulation of the noradrenergic system moderately enhanced the heart rhythm rigidity and β-adrenergic responsiveness of erythrocytes. In addition, it markedly augmented the moderating effect of subsequently administered propranolol on LF and VLF components in the heart rate variability and reversed the effect of propranolol on β-adrenergic responsiveness of erythrocytes.

View Article and Find Full Text PDF

Methylphenidate exerts dose-dependent effects on glutamate receptors and behaviors.

Biol Psychiatry

December 2014

Department of Physiology and Biophysics, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York; Department of Physiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China. Electronic address:

Background: Methylphenidate (MPH), a psychostimulant drug used to treat attention-deficit/hyperactivity disorder, produces the effects of increasing alertness and improving attention. However, misuse of MPH has been associated with an increased risk of aggression and psychosis. We sought to determine the molecular mechanism underlying the complex actions of MPH.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!